Hefler et al.[37] reported that simultaneous presence of three homozygote genotypes (2578/CC, 1154/GG and 634/CC) increased the serum levels of VEGF and was correlated with shorter survival, among 563 patients with ovarian cancer. The gene discussed is VEGFA; the disease is ovarian cancer.